新型α、β肾上腺素能阻滞剂拉贝洛尔的降压作用
Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
作者信息
Hansson L, Hänel B
出版信息
Int J Clin Pharmacol Biopharm. 1976 Oct;14(3):195-8.
PMID:12115
Abstract
Labetalol (AH5158) a new alpha- and beta-adrenergic blocking agent was given to 12 hypertensive patients for an average of 7 months. Statistically significant and clinically relevant reductions of blood pressure both in the recumbent and standing positions were observed. Side effects were few and the absence of postural hypotension was noted.
摘要
拉贝洛尔（AH5158），一种新型的α和β肾上腺素能阻滞剂，给予12例高血压患者，平均用药7个月。观察到卧位和立位血压均有统计学显著且临床相关的降低。副作用很少，且未发现体位性低血压。
Zotero 插件